BioNotebook: Big bets in life science venture capital; Chimerix stock offering; IPOs and dealmaking abound
This article was originally published in Scrip
Executive Summary
Coherus raises $55m, Nurix gets $25.1m as VC funding balloons; New IPO filings despite recent price-cutting; Chimerix offering grosses $103.8m; Sarepta buys manufacturing facility; and Ventrus/Assembly merge.